ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0032

Quantification of the Escape from X Chromosome Inactivation with the Million Cell-scale Human Blood Single-cell RNA-seq Datasets Reveals Heterogeneity of Escape Across Immune Cells and Escape in the Autoimmune Disease Conditions

Yoshihiko Tomofuji1, Ryuya Edahiro1, Yuya Shirai1, Kyuto Sonehara2, Qingbo Wang1, Atsushi Kumanogoh1 and Yukinori Okada3, 1Osaka University, Suita, Japan, 2University of Tokyo, Tokyo, Japan, 3University of Tokyo / Osaka University / RIKEN, Tokyo, Japan

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, gender, Gene Expression, genetics, immunology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0013–0039.5) Genetics, Genomics & Proteomics Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Understanding the differences in the immune system between sexes is important to elucidate the pathogenesis of autoimmune diseases which are more prevalent in females than males. One of the two X chromosomes of females is silenced through X chromosome inactivation (XCI) to compensate for the difference in the X chromosome dosage between sexes. There exist several genes which ‘escape’ from XCI, which could contribute to the differential gene expression between sexes. The differences in the escape across cell types are still poorly characterized, especially across immune cell types, even though a large number of immune-related genes are located on the X chromosome. Although previous studies suggested that abnormal escape of a few immune-related genes could contribute to autoimmune diseases, systematic evaluation of the association between escape and autoimmune diseases has not been conducted.

Methods: We investigated the escape across immune cell types utilizing the largest scale scRNA-seq datasets

(1) ~1,000,000 peripheral blood mononuclear cells (PBMCs) from 489 East Asian participants (Asian Immune Diversity Network), (2) ~1,000,000 PBMCs from 147 Japanese (72 COVID19 patients and 75 healthy participants) (3) ~1,000,000 PBMCs from 162 systematic lupus erythematosus patients and 99 healthy participants including East Asian and European.

We performed differential expression gene (DEG) analysis between sexes across immune cell types. In addition, we newly developed a method, single-cell Level inactivated X chromosome mapping (scLinaX), which directly quantifies gene expression from the inactivated X chromosome (Xi). Although the previous studies required plate-based scRNA-seq data which had rich per-cell information at the cost of throughput and cost efficiency for analyzing escape, scLinaX could be applied to the droplet-based scRNA-seq data which are high throughput and widely used.

Results: DEG analysis for each immune cell type revealed that degree of female-biased expression of escapee genes was stronger in lymphocytes than in myeloid cells (Figure 1). The scLinaX successfully detected the gene expression from the Xi for the previously reported escapee genes (Figure 2). The scLinaX revealed the stronger degree of escape in lymphocytes than in myeloid cells suggesting that difference in escape makes the heterogeneity of sex-associated differential gene expression across cell types (Figure 1). We also found several genes which had female-biased expression while showing little evidence of the escape in scLinaX analysis, emphasizing the limitation of DEG analysis and the importance of complementary analysis, such as the scLinaX. We evaluated the association between diseases (e.g. SLE) and escape and found little evidence of association, suggesting that abnormal escape in disease conditions might be not common but rather specific for a limited set of reported genes and cell types (Figure 3).

Conclusion: As demonstrated with several public datasets, scLinaX could be applied to a wide variety of scRNA-seq datasets. This study would contribute to expanding the current understanding of the XCI and escape and their contribution to autoimmune diseases.

Supporting image 1

Degree of escape tended to be higher in lymphoid cells than in myeloid cells. The plots indicate the result of the comparison of log2 fold changes in the DEG analysis (left) and the ratio of the expression from the inactivated X chromosome (right) between CD4 positive T cells (x-axis) and monocytes (y-axis). The dashed lines indicate y = x.

Supporting image 2

The scLinaX successfully detected the escape from the inactivated X chromosome for the previously reported escapee genes. A plot indicating the ratio of the gene expression from inactivated X chromosome quantified by scLinaX (y-axis) and the positions on the X chromosome (x-axis). The color of the points indicates whether the genes escape from the X chromosome inactivation or not based on the previous literature. The error bar indicates the standard deviations.

Supporting image 3

Comparison of the ratio of the gene expression from inactivated X chromosome between healthy control (HC) subjects (x-axis) and systemic lupus erythematosus (SLE) subjects (y-axis). The error bar indicates the standard deviations.


Disclosures: Y. Tomofuji: None; R. Edahiro: None; Y. Shirai: None; K. Sonehara: None; Q. Wang: None; A. Kumanogoh: None; Y. Okada: None.

To cite this abstract in AMA style:

Tomofuji Y, Edahiro R, Shirai Y, Sonehara K, Wang Q, Kumanogoh A, Okada Y. Quantification of the Escape from X Chromosome Inactivation with the Million Cell-scale Human Blood Single-cell RNA-seq Datasets Reveals Heterogeneity of Escape Across Immune Cells and Escape in the Autoimmune Disease Conditions [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/quantification-of-the-escape-from-x-chromosome-inactivation-with-the-million-cell-scale-human-blood-single-cell-rna-seq-datasets-reveals-heterogeneity-of-escape-across-immune-cells-and-escape-in-the-a/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantification-of-the-escape-from-x-chromosome-inactivation-with-the-million-cell-scale-human-blood-single-cell-rna-seq-datasets-reveals-heterogeneity-of-escape-across-immune-cells-and-escape-in-the-a/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology